The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Mayer Brown

1221 AVENUE OF THE AMERICAS, NEW YORK, NY 10020-1001, USA
Tel:
Work +1 212 506 2500
Fax:
Fax +1 212 262 1910
Email:
Web:
www.mayerbrown.com

Lisa Ferri

Tel:
Work +1 212 506 2340
Email:
Mayer Brown

Work Department

Intellectual Property

Position

Lisa M. Ferri is a partner in Mayer Brown's Intellectual Property practice and serves as the IP Practice Leader for the New York Office. She focuses her practice on the trial and appeal of patent and other complex intellectual property matters with particular emphasis in the life sciences field. Lisa serves as lead counsel on behalf of high-profile companies in federal courts across the country, Patent Office Inter Partes reviews, the International Trade Commission and the Federal Circuit Court of Appeals. Lisa has been recognized by clients and peers as a leading lawyer in intellectual property. She was named one of the "Top 250 Women in IP" by Managing Intellectual Property and an "IP Star" and "Life Sciences Star" by the Legal Media Group. She was also recognized in the area of patent litigation by the "Legal 500." Her recent victory at the Federal Circuit Court of Appeals in Biogen IDEC, Inc. and Genentech v. GlaxoSmithKline, which involved the monoclonal antibody therapy Arzerra®, was shortlisted for "Patent Impact Case of the Year" by the LMG Life Sciences Awards. Lisa’s life sciences practice spans a broad range of therapeutic areas and technologies—from pharmaceuticals and biologics for the treatment of HIV/AIDS, cancer, hepatitis, influenza, auto-immunities, emesis and BPH, to drug delivery systems, research tools, recombinant DNA, RNAi and a variety of medical devices. Her pharmaceutical practice focuses on representing innovator companies in cases brought pursuant to the Hatch-Waxman Act. She has successfully defended a number of key blockbuster drugs. Following enactment of the AIA, Lisa handled one of the first co-pending Patent Office Inter Partes Reviews and district court litigations relating to an Orange Book listed patent. Lisa also counsels clients regarding product life-cycle management and advises on the protection, enforcement and licensing of intellectual property portfolios. In addition, Lisa is an adjunct professor at Fordham University School of Law where she teaches Patent Litigation. She served as law clerk to Chief Judge Edward D. Re, U.S. Court of International Trade, who also sat by designation on a number of courts of appeal including the Federal Circuit.

Education

Seton Hall University Law School, JD Editor of the Seton Hall Law Review University of Virginia, BA


United States: Intellectual property

Patent litigation: full coverage

Within: Patent litigation: full coverage

Mayer Brown focuses on the technology and life sciences sectors, flanked by expertise in the telecoms and consumer goods industries. Alan Grimaldi in Washington DC, New York’s Lisa Ferri and Gabriela Kennedy in Hong Kong direct the practice. In Washington DC, appellate expert Andrew Pincus led the successful representation of Impression Products in a much-publicised Supreme Court case regarding the patent owner’s right to post-sale product control. The team also acted as co-lead for plaintiffs Gilead Sciences and Emory University in Hatch-Waxman litigation against Mylan, involving patents on blockbuster HIV drug Truvada. Additionally, the group assisted LG Electronics with an international arbitration against Nokia regarding FRAND rates for patents on cellular standards. Other clients include Endo Pharmaceuticals, Google and Marvell Semiconductor. Joseph Mahoney in Chicago, John Mancini, Jamie Beaber and Colleen Tracy James in New York as well as Stephen Baskin in the Washington DC office, are the key contacts.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to